Updated definitions of healthy ranges for serum alanine aminotransferase levels. - Wikidata - awgldk - TriplyDB

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

http://www.wikidata.org/entity/Q44047068

about

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease KASL clinical practice guidelines: management of chronic hepatitis B The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome Alanine aminotransferase-old biomarker and new concept: a review Persistent hypertransaminasemia in asymptomatic children: a stepwise approach Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines Antiviral therapy for chronic hepatitis B in China Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers Serum hepatic enzyme activity and alcohol drinking status in relation to the prevalence of metabolic syndrome in the general Japanese population Neck circumference, along with other anthropometric indices, has an independent and additional contribution in predicting fatty liver disease A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B Diagnosis, management, and treatment of hepatitis C: an update Current role of transient elastography in the management of chronic hepatitis B patients Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B.Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Statins in liver disease: a molehill, an iceberg, or neither?Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels.Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections.Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program.Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.Predicting the presence of hepatitis B virus surface antigen in Chinese patients by pathology data mining.Expression pattern of serum cytokines in hepatitis B virus infected patients with persistently normal alanine aminotransferase levels.Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis To treat or not to treat the "immunotolerant phase" of hepatitis B infection: A tunnel of controversy.Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey Diagnostic performance of traditional hepatobiliary biomarkers of drug-induced liver injury in the rat.Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients Meaning of upper limit of normal range of post-load 1-h plasma glucose level defined by oral glucose tolerance test in Japanese subjects.Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status.Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy.Histological and clinical characteristics of patients with chronic hepatitis C and persistently normal alanine aminotransferase levels Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study Nonalcoholic fatty liver disease: Diagnostic biomarkers.Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study Fatty liver disease in children: eat now pay later.Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks

P2860

Q24800420-66CA940F-F320-40EA-A0EB-D36BEB5EEF60 Q26752475-B2CB4083-083B-46DD-B1CB-41058262394D Q26777980-15F1F161-EB5A-4A18-BC8C-63626E95CC2B Q26828765-0FA57B0A-D8E7-4E9E-A7E9-05F4A96D1D68 Q26828819-77CA0CC4-CCB9-4369-8BC0-B3D7FBEF4CC1 Q26829883-27BC76CF-B98B-43A7-A16A-28CBB065DFC4 Q26858875-68DDF730-4182-4B3A-ACF3-6AF3E4B879A8 Q27000080-C278E48D-6EAF-4A7F-8EA6-93D5691954F1 Q27006557-2EBEC49D-4F06-405B-8D27-A1D767FDEDDB Q28386713-EE25E081-CBBB-4069-AFD1-D7AC1D0D067E Q28538138-BC591194-AEF3-4175-A82F-1BE008DC322F Q28543519-1395F677-CF79-4CF3-8139-C78D3B123D16 Q28546931-728F939E-58A4-4E7D-9215-D075C7142CED Q28741501-1AEFB5BB-2AE1-49AA-8B5E-A0A7BE89066F Q29619682-0C616165-EA61-4B68-BCD9-7AA5B1C09F95 Q30358894-375BDA41-0508-416A-B9EB-DE4CC8C6E339 Q30383907-F465026A-5316-4540-9901-3565004B2EDB Q30391932-C03FD89A-EFE2-4F18-AE05-B4BBBB8E8D95 Q30446668-344D21FB-9719-468B-A869-B3DF1F559F02 Q30468484-0180A609-27B0-471F-8136-6F7A28DF3096 Q30558355-8971FCCF-BC0C-4CE0-A3BE-A223ADF877DD Q30577903-BE5A117D-C501-4320-A630-DE1C8B1ED32F Q30589720-DFAD52E5-1D97-46FD-B395-19169D09ECD5 Q30647985-BB6129D3-23BE-41EA-8BFF-C38DBB8A8DE9 Q31126611-D4C53BED-22AF-48C8-8D11-C5089494E853 Q33304235-09D87B78-4216-4467-AEFE-0B8018A2FF38 Q33563893-80B351A2-8D5C-47B0-8D29-434E53AB9B01 Q33575324-8568ABA5-21F1-4097-93EF-3EB8AA11D037 Q33577715-3CF0A653-2EC7-4933-ADB4-B1075C1EC289 Q33599576-5630EFFE-FECB-4C4D-847A-104E6AB9ACB2 Q33607630-D671A8AB-E4E3-4089-B5ED-2DBE25D1BE54 Q33609481-89E25027-077C-463D-8D10-5E79498E5EEC Q33627245-20E9A211-E341-4DE9-98C1-4B3053FDCAEA Q33660486-62DA4FFC-48E8-41F9-B0F7-F6A1DF9F06DE Q33687762-2B9EE4F7-583F-4FC9-A740-2CDF6B0683B1 Q33706254-D194C3DE-C98A-4263-86B9-8C670D1FF32C Q33709267-0ED36F41-6248-4062-9A65-5816113FA581 Q33718945-410EB699-04AA-4721-AC2E-ADE650EE397A Q33718958-1FF008F0-1E5A-4D13-B66F-9F22536502B8 Q33753902-93F8B21C-19DB-4863-8D3C-92031D072D21

P2860

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

http://www.wikidata.org/entity/Q44047068

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

@en

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

@nl

type

label

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

@en

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

@nl

prefLabel

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

@en

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

@nl

P1433

Q44047068-08B69A6C-C9A0-4DA7-93AF-385192653EC5

P1476

Q44047068-3CADCA6E-6561-409F-8447-097207F6D81E

P2093

Q44047068-047A604D-AF1C-4D00-9353-6F902590ED49

Q44047068-115E9D94-841A-4F4C-944A-D0499C63491A

Q44047068-1647D1AA-4E2F-49D6-B7F6-B655CC5AF7FB

Q44047068-22D40690-CCCD-4EBE-BE51-A882861B05B0

Q44047068-2D866471-C43B-4636-AA1A-0F0555728EE9

Q44047068-4D9D3A72-4275-42A7-BD37-4B3E8D3A9C1F

Q44047068-95E04E0B-CFD3-432D-AEC8-2B74A0C132F6

Q44047068-9A8189FE-9978-48BB-AAD0-BFB2A27C0A1C

Q44047068-A7232A4C-4EB6-448C-8702-87AF3BB03F86

Q44047068-BD32078F-F80C-48BD-A2B6-33B3B9FEA766

P304

Q44047068-13E2F9F8-A5C6-4828-922B-9577720C3377

P31

Q44047068-63D5B432-77E4-4126-BC68-32DA593495DE

P356

Q44047068-21D29E35-F910-426E-B254-48EE749C6E25

P407

Q44047068-99344DAD-55CF-4992-984B-319E5A578845

P433

Q44047068-76C04CF5-2046-466E-8367-0D7F97F8FF7F

P478

Q44047068-936D3143-3D18-41C6-BCBF-F0459D3F1016

P50

Q44047068-E423C79F-3AD6-494E-8DF6-FE34CD0DEDCD

P577

Q44047068-2CE70736-4739-41A6-971A-EFB8AD6F2B8E

P698

Q44047068-FDB88464-2059-4CDA-AA0E-6A50C7F08C22

P356

0003-4819-137-1-200207020-00006

P1433

Annals of Internal Medicine

P1476

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

@en

P2093

Alberto Zanella

http://www.w3.org/2001/XMLSchema#string

Dario Conte

http://www.w3.org/2001/XMLSchema#string

Emanuela Del Vecchio

http://www.w3.org/2001/XMLSchema#string

Emanuela Della Torre

http://www.w3.org/2001/XMLSchema#string

Emanuela Taioli

http://www.w3.org/2001/XMLSchema#string

Francesco Zanuso

http://www.w3.org/2001/XMLSchema#string

Fulvio Mozzi

http://www.w3.org/2001/XMLSchema#string

Girolamo Sirchia

http://www.w3.org/2001/XMLSchema#string

Luciana Vianello

http://www.w3.org/2001/XMLSchema#string

Massimo Colombo

http://www.w3.org/2001/XMLSchema#string

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-137-1-200207020-00006

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12093239

http://www.w3.org/2001/XMLSchema#string